The Difference of Anti-HBs Levels in Babies Vaccinated with Hepatitis B Vaccine Between at 2, 4, 6 Months with 2, 3, 4 Months Schedule in Denpasar

Vania Catleya Estina; I Gusti Ngurah Sanjaya Putra; Dyah Kanya Wati; Hendra Santoso; I Gusti Agung Ngurah Sugitha Adnyana; Komang Ayu Witarini

doi:doi:10.11648/j.ajp.20220801.12

The Difference of Anti-HBs Levels in Babies Vaccinated with Hepatitis B Vaccine Between at 2, 4, 6 Months with 2, 3, 4 Months Schedule in Denpasar

Vania Catleya Estina, I Gusti Ngurah Sanjaya Putra, Dyah Kanya Wati, Hendra Santoso, I Gusti Agung Ngurah Sugitha Adnyana, Komang Ayu Witarini

Published in American Journal of Pediatrics (Volume 8, Issue 1)

Received: 8 December 2021 Accepted: 6 January 2022 Published: 12 January 2022

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Background: Hepatitis B virus is one of the causes of the major health problem throughout the world. Hepatitis B vaccine is one way to control HBV infections effectively. The prevalence of HB infection shows a decreased effectivity of Hepatitis B vaccination. Objective: To discover the differences in anti-HBs levels between two schedules of vaccination recommended by the Indonesian Pediatric Society (at 2, 4, 6 months vs 2, 3, 4 months of age). Methods: This was an observational study on healthy babies comparing the effect of two treatment groups, each consisting of 30 subjects. Subjects were chosen by stratified random sampling. Blood samples were withdrawn three months after the subjects received their last dose of Hepatitis B vaccination, either in 2, 4, 6 months schedule (Group 1) or in 2, 3, 4 months schedule (Group 2). We used the independent t-test to assess the mean differences between the anti-HBs levels of the two groups. A p-value of<0.05 was considered statistically significant. Results: We found a significant difference in anti-HBs levels between Group 1 and Group 2 (820.06 mIU/ml vs 540.54 mIU/ml, respectively, p=0.002). Conclusion: Both vaccination schedules produced protective anti-HBs levels three months after the completed schedule. The anti-HBs level in group 1 produced higher anti-HBs level compared to Group 2.

Published in	American Journal of Pediatrics (Volume 8, Issue 1)
DOI	10.11648/j.ajp.20220801.12
Page(s)	6-9
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Children, Hepatitis B, Anti-HBs, Vaccination, Indonesia

References

[1]	Terrault NA, Bzowej NH, Chang KM, et al. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2016; 63 (1): 261-283. doi: 10.1002/hep.28156.
[2]	World Health Organization. WHO manual for the establishment of national and other secondary standards for vaccines. Geneva: World Health Organization Publication; 2011. Available at: https://apps.who.int/iris/handle/10665/70669.
[3]	Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med. 1997; 336 (26): 1855-1859. doi: 10.1056/NEJM199706263362602.
[4]	Chen HL, Chang CJ, Kong MS, Huang FC, Lee HC, Lin CC, et al. Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination. Hepatology. 2004; 39 (1): 58-63. doi: 10.1002/hep.20006.
[5]	Armstrong GL, Mast EE, Wojczynski M, Margolis HS. Childhood hepatitis B virus infections in the United States before hepatitis B immunisation. Pediatrics. 2001; 108 (5): 1123-1128. doi: 10.1542/peds.108.5.1123.
[6]	Chang MH, Shau WY, Chen CJ, Wu TC, Kong MS, Liang DC, et al. Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls. JAMA. 2000; 284 (23): 3040-3042. doi: 10.1001/jama.284.23.3040.
[7]	Chongsrisawat V, Theamboonlers A, Khwanjaipanich S, Owatanapanich S, Sinlaparatsamee S, Poovorawan Y. Humoral immune response following hepatitis B vaccine booster dose in children with and without prior immunisation. Southeast Asian J Trop Med Public Health. 2000; 31 (4): 623-626.
[8]	Lin YC, Chang MH, Ni YH, Hsu HY, Chen DS. Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan. J Infect Dis. 2003; 187 (1): 134-138. doi: 10.1086/345871.
[9]	Petersen KM, Bulkow LR, McMahon BJ, Zanis C, Getty M, Peters H, et al. Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth. Pediatr Infect Dis J. 2004; 23 (7): 650-655. doi: 10.1097/01.inf.0000130952.96259.fd.
[10]	Banatvala JE, Van Damme P. Hepatitis B vaccine – do we need boosters? Journal of Viral Hepatitis. 2003; 10: 1-6. doi: 10.1046/j.1365-2893.2003.00400.x.
[11]	Jafarzadeh A, Montazerifar SJ. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth. J Ayub Med Coll Abbottabad. 2006; 18 (4): 4-9.
[12]	Van Damme P, Moiseeva A, Marichev I, Kervyn AD, Booy R, Kuriyakose S, et al. Five years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11-15 years: a randomised controlled study. BMC Infect Dis. 2010; 10: 357. doi: 10.1186/1471-2334-10-357.
[13]	Girisha KM, Kamat JR, Nataraj G. Immunological response to two hepatitis B vaccines administered in two different schedules. Indian J Pediatr. 2006; 73 (6): 489-491. doi: 10.1007/BF02759892.
[14]	IPS Immunisation Task Force. Jadwal imunisasi rekomendasi IDAI (article in Indonesian). Sari Pediatri. 2000; 2 (1): 43-47. doi: 10.14238/sp2.1.2000.43-7.
[15]	Gunardi H, Kartasasmita CB, Hadinegoro SRS, Satari HI, Oswari H, Pusponegoro HD, et al. Jadwal Imunisasi Anak Usia 0–18 Tahun Rekomendasi Ikatan Dokter Anak Indonesia 2017 (article in Indonesian). Sari Pediatri. 2017; 18 (5): 417-22. doi: 10.14238/sp18.5.2017.417-22.
[16]	Zhang X, Wang J, Chen X, Yu M, Yu S, Sun Y, et al. Short-term immunogenicity of standard and accelerated hepatitis B virus vaccination schedules in healthy adults: a comparative field study in China. Biosci Rep. 2018; 38 (5): BSR20180846. doi: 10.1042/BSR20180846.
[17]	Rusmil K. Melengkapi/Mengejar Imunisasi (article in Indonesian). Indonesian Pediatric Society. Last updated: May 30, 2015. Last accessed: May 23, 2020. Available at: https://www.idai.or.id/artikel/klinik/imunisasi/melengkapi-mengejar-imunisasi-bagian-i.

Cite This Article

Plain Text BibTeX RIS

APA Style

Vania Catleya Estina, I Gusti Ngurah Sanjaya Putra, Dyah Kanya Wati, Hendra Santoso, I Gusti Agung Ngurah Sugitha Adnyana, et al. (2022). The Difference of Anti-HBs Levels in Babies Vaccinated with Hepatitis B Vaccine Between at 2, 4, 6 Months with 2, 3, 4 Months Schedule in Denpasar. American Journal of Pediatrics, 8(1), 6-9. https://doi.org/10.11648/j.ajp.20220801.12

Copy | Download

ACS Style

Vania Catleya Estina; I Gusti Ngurah Sanjaya Putra; Dyah Kanya Wati; Hendra Santoso; I Gusti Agung Ngurah Sugitha Adnyana, et al. The Difference of Anti-HBs Levels in Babies Vaccinated with Hepatitis B Vaccine Between at 2, 4, 6 Months with 2, 3, 4 Months Schedule in Denpasar. Am. J. Pediatr. 2022, 8(1), 6-9. doi: 10.11648/j.ajp.20220801.12

Copy | Download

AMA Style

Vania Catleya Estina, I Gusti Ngurah Sanjaya Putra, Dyah Kanya Wati, Hendra Santoso, I Gusti Agung Ngurah Sugitha Adnyana, et al. The Difference of Anti-HBs Levels in Babies Vaccinated with Hepatitis B Vaccine Between at 2, 4, 6 Months with 2, 3, 4 Months Schedule in Denpasar. Am J Pediatr. 2022;8(1):6-9. doi: 10.11648/j.ajp.20220801.12

Copy | Download

@article{10.11648/j.ajp.20220801.12,
  author = {Vania Catleya Estina and I Gusti Ngurah Sanjaya Putra and Dyah Kanya Wati and Hendra Santoso and I Gusti Agung Ngurah Sugitha Adnyana and Komang Ayu Witarini},
  title = {The Difference of Anti-HBs Levels in Babies Vaccinated with Hepatitis B Vaccine Between at 2, 4, 6 Months with 2, 3, 4 Months Schedule in Denpasar},
  journal = {American Journal of Pediatrics},
  volume = {8},
  number = {1},
  pages = {6-9},
  doi = {10.11648/j.ajp.20220801.12},
  url = {https://doi.org/10.11648/j.ajp.20220801.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajp.20220801.12},
  abstract = {Background: Hepatitis B virus is one of the causes of the major health problem throughout the world. Hepatitis B vaccine is one way to control HBV infections effectively. The prevalence of HB infection shows a decreased effectivity of Hepatitis B vaccination. Objective: To discover the differences in anti-HBs levels between two schedules of vaccination recommended by the Indonesian Pediatric Society (at 2, 4, 6 months vs 2, 3, 4 months of age). Methods: This was an observational study on healthy babies comparing the effect of two treatment groups, each consisting of 30 subjects. Subjects were chosen by stratified random sampling. Blood samples were withdrawn three months after the subjects received their last dose of Hepatitis B vaccination, either in 2, 4, 6 months schedule (Group 1) or in 2, 3, 4 months schedule (Group 2). We used the independent t-test to assess the mean differences between the anti-HBs levels of the two groups. A p-value ofResults: We found a significant difference in anti-HBs levels between Group 1 and Group 2 (820.06 mIU/ml vs 540.54 mIU/ml, respectively, p=0.002). Conclusion: Both vaccination schedules produced protective anti-HBs levels three months after the completed schedule. The anti-HBs level in group 1 produced higher anti-HBs level compared to Group 2.},
 year = {2022}
}

Copy | Download

TY  - JOUR
T1  - The Difference of Anti-HBs Levels in Babies Vaccinated with Hepatitis B Vaccine Between at 2, 4, 6 Months with 2, 3, 4 Months Schedule in Denpasar
AU  - Vania Catleya Estina
AU  - I Gusti Ngurah Sanjaya Putra
AU  - Dyah Kanya Wati
AU  - Hendra Santoso
AU  - I Gusti Agung Ngurah Sugitha Adnyana
AU  - Komang Ayu Witarini
Y1  - 2022/01/12
PY  - 2022
N1  - https://doi.org/10.11648/j.ajp.20220801.12
DO  - 10.11648/j.ajp.20220801.12
T2  - American Journal of Pediatrics
JF  - American Journal of Pediatrics
JO  - American Journal of Pediatrics
SP  - 6
EP  - 9
PB  - Science Publishing Group
SN  - 2472-0909
UR  - https://doi.org/10.11648/j.ajp.20220801.12
AB  - Background: Hepatitis B virus is one of the causes of the major health problem throughout the world. Hepatitis B vaccine is one way to control HBV infections effectively. The prevalence of HB infection shows a decreased effectivity of Hepatitis B vaccination. Objective: To discover the differences in anti-HBs levels between two schedules of vaccination recommended by the Indonesian Pediatric Society (at 2, 4, 6 months vs 2, 3, 4 months of age). Methods: This was an observational study on healthy babies comparing the effect of two treatment groups, each consisting of 30 subjects. Subjects were chosen by stratified random sampling. Blood samples were withdrawn three months after the subjects received their last dose of Hepatitis B vaccination, either in 2, 4, 6 months schedule (Group 1) or in 2, 3, 4 months schedule (Group 2). We used the independent t-test to assess the mean differences between the anti-HBs levels of the two groups. A p-value ofResults: We found a significant difference in anti-HBs levels between Group 1 and Group 2 (820.06 mIU/ml vs 540.54 mIU/ml, respectively, p=0.002). Conclusion: Both vaccination schedules produced protective anti-HBs levels three months after the completed schedule. The anti-HBs level in group 1 produced higher anti-HBs level compared to Group 2.
VL  - 8
IS  - 1
ER  -

Copy | Download

Author Information

Vania Catleya Estina

Department of Child Health, Medical Faculty of Udayana University, Sanglah General Hospital, Denpasar, Bali, Indonesia
I Gusti Ngurah Sanjaya Putra

Department of Child Health, Medical Faculty of Udayana University, Sanglah General Hospital, Denpasar, Bali, Indonesia
Dyah Kanya Wati

Department of Child Health, Medical Faculty of Udayana University, Sanglah General Hospital, Denpasar, Bali, Indonesia
Hendra Santoso

Department of Child Health, Medical Faculty of Udayana University, Sanglah General Hospital, Denpasar, Bali, Indonesia
I Gusti Agung Ngurah Sugitha Adnyana

Department of Child Health, Medical Faculty of Udayana University, Sanglah General Hospital, Denpasar, Bali, Indonesia
Komang Ayu Witarini

Department of Child Health, Medical Faculty of Udayana University, Sanglah General Hospital, Denpasar, Bali, Indonesia

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Vania Catleya Estina, I Gusti Ngurah Sanjaya Putra, Dyah Kanya Wati, Hendra Santoso, I Gusti Agung Ngurah Sugitha Adnyana, et al. (2022). The Difference of Anti-HBs Levels in Babies Vaccinated with Hepatitis B Vaccine Between at 2, 4, 6 Months with 2, 3, 4 Months Schedule in Denpasar. American Journal of Pediatrics, 8(1), 6-9. https://doi.org/10.11648/j.ajp.20220801.12

Copy | Download

ACS Style

Vania Catleya Estina; I Gusti Ngurah Sanjaya Putra; Dyah Kanya Wati; Hendra Santoso; I Gusti Agung Ngurah Sugitha Adnyana, et al. The Difference of Anti-HBs Levels in Babies Vaccinated with Hepatitis B Vaccine Between at 2, 4, 6 Months with 2, 3, 4 Months Schedule in Denpasar. Am. J. Pediatr. 2022, 8(1), 6-9. doi: 10.11648/j.ajp.20220801.12

Copy | Download

AMA Style

Vania Catleya Estina, I Gusti Ngurah Sanjaya Putra, Dyah Kanya Wati, Hendra Santoso, I Gusti Agung Ngurah Sugitha Adnyana, et al. The Difference of Anti-HBs Levels in Babies Vaccinated with Hepatitis B Vaccine Between at 2, 4, 6 Months with 2, 3, 4 Months Schedule in Denpasar. Am J Pediatr. 2022;8(1):6-9. doi: 10.11648/j.ajp.20220801.12

Copy | Download

@article{10.11648/j.ajp.20220801.12,
  author = {Vania Catleya Estina and I Gusti Ngurah Sanjaya Putra and Dyah Kanya Wati and Hendra Santoso and I Gusti Agung Ngurah Sugitha Adnyana and Komang Ayu Witarini},
  title = {The Difference of Anti-HBs Levels in Babies Vaccinated with Hepatitis B Vaccine Between at 2, 4, 6 Months with 2, 3, 4 Months Schedule in Denpasar},
  journal = {American Journal of Pediatrics},
  volume = {8},
  number = {1},
  pages = {6-9},
  doi = {10.11648/j.ajp.20220801.12},
  url = {https://doi.org/10.11648/j.ajp.20220801.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajp.20220801.12},
  abstract = {Background: Hepatitis B virus is one of the causes of the major health problem throughout the world. Hepatitis B vaccine is one way to control HBV infections effectively. The prevalence of HB infection shows a decreased effectivity of Hepatitis B vaccination. Objective: To discover the differences in anti-HBs levels between two schedules of vaccination recommended by the Indonesian Pediatric Society (at 2, 4, 6 months vs 2, 3, 4 months of age). Methods: This was an observational study on healthy babies comparing the effect of two treatment groups, each consisting of 30 subjects. Subjects were chosen by stratified random sampling. Blood samples were withdrawn three months after the subjects received their last dose of Hepatitis B vaccination, either in 2, 4, 6 months schedule (Group 1) or in 2, 3, 4 months schedule (Group 2). We used the independent t-test to assess the mean differences between the anti-HBs levels of the two groups. A p-value ofResults: We found a significant difference in anti-HBs levels between Group 1 and Group 2 (820.06 mIU/ml vs 540.54 mIU/ml, respectively, p=0.002). Conclusion: Both vaccination schedules produced protective anti-HBs levels three months after the completed schedule. The anti-HBs level in group 1 produced higher anti-HBs level compared to Group 2.},
 year = {2022}
}

Copy | Download

TY  - JOUR
T1  - The Difference of Anti-HBs Levels in Babies Vaccinated with Hepatitis B Vaccine Between at 2, 4, 6 Months with 2, 3, 4 Months Schedule in Denpasar
AU  - Vania Catleya Estina
AU  - I Gusti Ngurah Sanjaya Putra
AU  - Dyah Kanya Wati
AU  - Hendra Santoso
AU  - I Gusti Agung Ngurah Sugitha Adnyana
AU  - Komang Ayu Witarini
Y1  - 2022/01/12
PY  - 2022
N1  - https://doi.org/10.11648/j.ajp.20220801.12
DO  - 10.11648/j.ajp.20220801.12
T2  - American Journal of Pediatrics
JF  - American Journal of Pediatrics
JO  - American Journal of Pediatrics
SP  - 6
EP  - 9
PB  - Science Publishing Group
SN  - 2472-0909
UR  - https://doi.org/10.11648/j.ajp.20220801.12
AB  - Background: Hepatitis B virus is one of the causes of the major health problem throughout the world. Hepatitis B vaccine is one way to control HBV infections effectively. The prevalence of HB infection shows a decreased effectivity of Hepatitis B vaccination. Objective: To discover the differences in anti-HBs levels between two schedules of vaccination recommended by the Indonesian Pediatric Society (at 2, 4, 6 months vs 2, 3, 4 months of age). Methods: This was an observational study on healthy babies comparing the effect of two treatment groups, each consisting of 30 subjects. Subjects were chosen by stratified random sampling. Blood samples were withdrawn three months after the subjects received their last dose of Hepatitis B vaccination, either in 2, 4, 6 months schedule (Group 1) or in 2, 3, 4 months schedule (Group 2). We used the independent t-test to assess the mean differences between the anti-HBs levels of the two groups. A p-value ofResults: We found a significant difference in anti-HBs levels between Group 1 and Group 2 (820.06 mIU/ml vs 540.54 mIU/ml, respectively, p=0.002). Conclusion: Both vaccination schedules produced protective anti-HBs levels three months after the completed schedule. The anti-HBs level in group 1 produced higher anti-HBs level compared to Group 2.
VL  - 8
IS  - 1
ER  -

Copy | Download